Thiago Júlio

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Incorporation of new drugs for treatment of metastatic colorectal cancer (mCRC) has led to a clear improvement in overall patient survival, the added cost of treatment, however, is a major concern(More)
  • 1